BD (Becton, Dickinson and Company ) Overview
Company Headquarters: New Jersey, US
Founded: 1897
Workforce: ~77,000
Company Working: BD (Becton, Dickinson and Company) is a medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. The company operates in three main segments: BD Medical, BD Life Sciences, and BD Interventional. Its products and services are used in a wide range of medical settings, including hospitals, clinics, and research laboratories. BD's product portfolio includes a wide range of medical devices and instrument systems, including syringes, needles, catheters, diagnostic tests, and imaging systems. The company is also a leader in the development of healthcare software and data analytics solutions. BD's breast biopsy products are designed to improve the accuracy, speed, and safety of breast biopsy procedures, ultimately leading to better patient outcomes. BD has a significant global presence, with operations in over 190 countries around the world. The company has its presence across the Americas, Asia-Pacific, and Europe, and Middle East & Africa regions.
Strategy
BD's key strategy involves investing heavily in research and development to drive innovation and bring new products and solutions to market. The company also works with key partners, including other companies, healthcare providers, and governments, to develop new products and solutions and expand its reach in key markets. BD is actively expanding into new markets, particularly in emerging markets, to capture new opportunities for growth, and is focused on using digital technologies to improve the efficiency and effectiveness of its operations and provide new solutions for customers.
